• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

DarioHealth wins Australian approval for glucose meters designed for latest iPhones

December 18, 2017 By Sarah Faulkner

Dario HealthDarioHealth (NSDQ:DRIO) said today that authorities in Australia approved the version of its blood glucose monitoring system that fits with the Lightning connector on Apple’s iPhone 7, 8 and X smartphones.

Users in Australia will be able to buy the Lightning-enabled Dario device by Jan. 2018, the Israel-based company reported.

“We are thrilled to announce that DarioHealth secured TGA approval to offer the Lightning-enabled version and can now accommodate users in Australia who have updated their Apple devices,” chairman & CEO Erez Raphael said in prepared remarks. “We hope to help the 1.7 million Australians who have diabetes, specifically the more than 100,000 Australians who have been diagnosed with diabetes in the past year.”

The company said it expects to win approval for its technology in the U.S. and Canada in the coming months.

DRIO shares were trading at $1.60 apiece in mid-morning activity today, up 6.9%.

DarioHealth’s platform includes a blood glucose monitoring system, which connects via a headphone jack to a mobile device, a lancing device and test strips, which help diabetes patients monitor their blood glucose throughout the day. There is no carrying case or batteries, according to DarioHealth, and users can access real-time and historical blood glucose data to watch out for trends.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Regulatory/Compliance, Wall Street Beat Tagged With: dariohealth

IN CASE YOU MISSED IT

  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor
  • Medtronic to separate Diabetes business unit

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS